News & Insights

Person

Date

  • Filter by dates

Active filters:

26.06.2023

We advised WSE-listed Pure Biologics S.A. on a PLN 12 million financing transaction

We advised WSE-listed Pure Biologics S.A. in a transaction to raise PLN 12 million in financing from a new investor, ACRX Investments Ltd. The transa...

Case studies
NEW!
We advised WSE-listed Pure Biologics S.A. on a PLN 12 million financing transaction

23.12.2022

GESSEL advises Pure Biologics S.A., a company listed on the Warsaw Stock Exchange

GESSEL supported Pure Biologics S.A. and its shareholders in preparation of a prospect-less public share offering via the accelerated book building process and execution...

Case studies
GESSEL advises Pure Biologics S.A., a company listed on the Warsaw Stock Exchange

18.11.2022

GESSEL advises Cavatina Holding S.A. on another public bond placement valued at PLN 16.5 mln

Cavatina Holding S.A. is continuing its planned sequence of bond offerings, bringing to the market P2022D series bonds with a value of PLN 16.5 mln – which, in conjuncti...

News
GESSEL advises Cavatina Holding S.A. on another public bond placement valued at PLN 16.5 mln